RxSight, Inc. (RXST) Tops Q3 EPS by 24c

RxSight, Inc. (NASDAQ: RXST) reported Q3 EPS of ($0.19), $0.24 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $22.2 million versus the consensus estimate of $20.55 million.

For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.

You May Also Be Interested In

• Wolfe upgrades AT&T to Outperform as improving fundamentals outweigh Starlink risk
• First Mid Bancshares, Inc. (FMBH) Tops Q2 EPS by 24c
• Heritage Financial (HFWA) Tops Q2 EPS by 12c